1-9 of 9
Gregory R. Pond
Close
Sort by
Journal Articles

Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphomas

Amaris K. Balitsky, Gregory R Pond, Graeme Fraser, Tom Kouroukis, Stephen Ronan Foley
Journal: Blood
Blood (2022) 140 (Supplement 1): 8036–8037.
https://doi.org/10.1182/blood-2022-165674
Published: 2022
Journal Articles

Causes of Death Among Patients with Multiple Myeloma: A 10 Year Longitudinal Analysis of a Population-Based Cohort in Ontario, Canada

Arleigh McCurdy, Hsien Seow, Gregory R Pond, Anastasia Gayowsky, Rajshekhar Chakraborty, Alissa Visram, Rayan Kaedbey, Anita D'Souza, Ghulam Rehman Mohyuddin, Rafael Fonseca, Hira S Mian
Journal: Blood
Blood (2022) 140 (Supplement 1): 427–429.
https://doi.org/10.1182/blood-2022-157815
Published: 2022
Journal Articles

Variable Frailty Categorization Among Real-World Patient with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Hira S Mian, Martha L Louzada, Arleigh McCurdy, Ruthanne Cameron, Gregory R Pond, Tanya Wildes, Darryl Leong
Journal: Blood
Blood (2022) 140 (Supplement 1): 2395–2396.
https://doi.org/10.1182/blood-2022-158301
Published: 2022
Journal Articles

Is Symptom Burden Associated with Health Care Utilization: A Longitudinal Population-Based Cohort Study of Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma

Hira S Mian, Rinku Sutradhar, Gregory R Pond, Branavan Sivapathasundaram, Anita D'Souza, Tanya M. Wildes, Hsien Seow
Journal: Blood
Blood (2021) 138 (Supplement 1): 116.
https://doi.org/10.1182/blood-2021-146862
Published: 2021
Journal Articles

Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study

Hira S Mian, MD, Gregory R Pond, PhD PStat, Tanya M. Wildes, MD MSCI, Branavan Sivapathasundaram, MSc, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-133869
Published: 2020
Journal Articles

Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes

Hira S Mian, MD, Gregory R Pond, PhD PStat, Branavan Sivapathasundaram, MSc, Tanya M. Wildes, MD MSCI, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133369
Published: 2020
Journal Articles

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Hira S Mian, MD, Gregory R Pond, PhD PStat, Sascha A Tuchman, MD, Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI
Journal: Blood
Blood (2019) 134 (Supplement_1): 4774.
https://doi.org/10.1182/blood-2019-122261
Published: 2019
Journal Articles

Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort

Hira S Mian, MD, C. Tom Kouroukis, MDMSc,FRCPC, Gregory R Pond, PhD PStat, Hsien Seow, PhD, Jonathan Sussman, MD FRCPC, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 268.
https://doi.org/10.1182/blood-2019-121672
Published: 2019
Journal Articles

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

Bing Z. Carter, Marcela Gronda, Zhiliang Wang, Kate Welsh, Clemencia Pinilla, Michael Andreeff, Wendy D. Schober, Adel Nefzi, Gregory R. Pond, Imtiaz A. Mawji, Richard A. Houghten, John Ostresh, Joseph Brandwein, Mark D. Minden, Andre C. Schuh, Richard A. Wells, Hans Messner, Kathy Chun, John C. Reed, Aaron D. Schimmer
Journal: Blood
Blood (2005) 105 (10): 4043–4050.
https://doi.org/10.1182/blood-2004-08-3168
Published: 2005